Literature DB >> 22511693

Is it time for medicine-based evidence?

John Concato.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22511693     DOI: 10.1001/jama.2012.482

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  While modern medicine evolves continuously, evidence-based research methodology remains: how register studies should be interpreted and appreciated.

Authors:  Eleonor Svantesson; Eric Hamrin Senorski; Kurt P Spindler; Olufemi R Ayeni; Freddie H Fu; Jón Karlsson; Kristian Samuelsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-08       Impact factor: 4.342

2.  Comparative effectiveness research.

Authors:  J A Hirsch; P W Schaefer; J M Romero; J D Rabinov; P C Sanelli; L Manchikanti
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-29       Impact factor: 3.825

3.  Cost-effectiveness data: Are neurologists in practice equipped to interpret them?

Authors:  Saty Satya-Murti
Journal:  Neurol Clin Pract       Date:  2013-10

4.  Comparative effectiveness of cardiac resynchronization therapy in combination with implantable defibrillator in patients with heart failure and wide QRS duration.

Authors:  Kenneth C Bilchick; George J Stukenborg
Journal:  Am J Cardiol       Date:  2014-08-27       Impact factor: 2.778

5.  The use of clinical trials in comparative effectiveness research on mental health.

Authors:  Carlos Blanco; Claudia Rafful; Mark Olfson
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

6.  Feasibility of a quality improvement strategy integrating psychosocial care into 28 medical cancer centers (HuCare project).

Authors:  Rodolfo Passalacqua; Maria Antonietta Annunziata; Claudia Borreani; Francesca Diodati; Luciano Isa; Jessica Saleri; Claudio Verusio; Caterina Caminiti
Journal:  Support Care Cancer       Date:  2015-05-10       Impact factor: 3.603

7.  Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating chronic dialysis.

Authors:  Sally K Rigler; James B Wetmore; Jonathan D Mahnken; Lei Dong; Edward F Ellerbeck; Theresa I Shireman
Journal:  BMC Nephrol       Date:  2013-02-27       Impact factor: 2.388

8.  Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to date.

Authors:  Thrasivoulos Tzellos; Athanassios Kyrgidis; Anastasia Trigoni; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2012-07-01

9.  Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy.

Authors:  Jennifer R Kramer; Jennifer Arney; John Chen; Peter Richardson; Zhigang Duan; Richard L Street; Marilyn Hinojosa-Lindsey; Aanand D Naik; Hashem B El-Serag
Journal:  BMC Health Serv Res       Date:  2012-08-28       Impact factor: 2.655

10.  Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.

Authors:  C M Booth; I F Tannock
Journal:  Br J Cancer       Date:  2014-01-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.